RAJPOOT, M.; SINGH, D.; PANDEY, K. .; BHARGAVA, R. Safety and efficacy of cyclosporine (0.05% versus 0.09%) in dry eye disease. Is it the strength of cyclosporin that really matters? . Nepalese Journal of Ophthalmology, [S. l.], v. 14, n. 2, p. 64–77, 2022. DOI: 10.3126/nepjoph.v14i2.38928. Disponível em: https://www.nepjol.info/index.php/NEPJOPH/article/view/38928. Acesso em: 16 jun. 2024.